UHS Q2 EPS $4.26 vs $2.42 YoY; raises 2024 guidance; adds $1B to buyback

UNIVERSAL HEALTH SERVICES INC

2024-Q2 EPS reported $8.08 revenue$7,751,186,000

Q2 net income $289.2M ($4.26 diluted EPS) vs $171.3M ($2.42) YoY; adjusted EPS $4.31.
Net revenues $3.908B (+10.1% YoY); same-facility acute revenue +6.6%, behavioral +11.0%.
Revised 2024 guidance: Adj. EPS $15.40-$16.20 (prev $13.00-$14.00); Adj. EBITDA $2.154B-$2.226B (prev $1.931B-$2.019B).
Board authorizes $1B increase to stock repurchase program; total authorization now $1.228B.
Operating cash flow $1.076B through June 2024 vs $654M in 2023, up 64%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.